首页 > 最新文献

The Homoeopathic physician最新文献

英文 中文
Effect of COVID-19 Pandemic on Anti-VEGF Treatment of Medical Retinal Conditions COVID-19大流行对抗vegf治疗医学视网膜疾病的影响
Pub Date : 2020-12-27 DOI: 10.38192/1.6.3.10
M. Rahimzadeh, R. Muniraju, S. Izadi
Introduction: Ophthalmology services have been significantly impacted by the COVID-19 pandemic. Frequency of intravitreal anti-vascular endothelial growth factor (Anti-VEGF) injections are important in visual outcomes.Methods: We conducted an audit on intravitreal services in an NHS district general hospital in the UK including all new patients with diabetic macular oedema (CI-DMO) and wet age-related macular degeneration (AMD) who were initiated on intravitreal injection of Aflibercept (EYLEA) between 1st January to 15th July 2020, and had subsequent injections until October 2020. Data on injection dates and visual acuity was extracted, and the total number of all intravitreal injections for all indications between January to September 2020 and the same period in 2019. Delay to treatment was defined as more than 14 days, according to the fixed dosing schedule.Results: We found 31% (n=17) of patients initiated on treatment for wet AMD and 44% (N=11) for CI-DMO had delayed injections.  There was no correlation between total duration of delay and change in best-corrected visual acuity (BCVA). Similarly, we found no association between duration of delay and change in BCVA. The number of intravitreal injections declined during the COVID-19 pandemic by 17.8% compared to 2019.Conclusion: Majority of patients initiated on anti-VEGF injections just before the pandemic or during the pandemic received injections on time. Where there were significant delays to treatment, there was no detected loss in vision over the short term. However, the long-term impact and impact of overall reduction in intravitreal injections are unknown.
导语:受新冠肺炎疫情影响,眼科服务受到显著影响。玻璃体内注射抗血管内皮生长因子(Anti-VEGF)的频率对视力结果很重要。方法:我们对英国一家NHS地区综合医院的玻璃体内服务进行了审计,包括所有在2020年1月1日至7月15日期间开始玻璃体内注射阿非利西普(EYLEA)的糖尿病性黄斑水肿(CI-DMO)和湿性年龄相关性黄斑变性(AMD)的新患者,随后注射到2020年10月。提取注射日期和视力数据,以及2020年1月至9月与2019年同期所有适应症的玻璃体内注射总数。根据固定给药计划,延迟治疗定义为超过14天。结果:我们发现31% (n=17)的湿性AMD患者开始治疗,44% (n= 11)的CI-DMO患者延迟注射。延迟总时间与最佳矫正视力(BCVA)变化无相关性。同样,我们发现延迟时间与BCVA变化之间没有关联。在2019冠状病毒病大流行期间,玻璃体内注射次数比2019年下降了17.8%。结论:大多数患者在大流行前或大流行期间开始注射抗vegf。在严重延误治疗的情况下,短期内没有发现视力下降。然而,长期影响和整体减少玻璃体内注射的影响尚不清楚。
{"title":"Effect of COVID-19 Pandemic on Anti-VEGF Treatment of Medical Retinal Conditions","authors":"M. Rahimzadeh, R. Muniraju, S. Izadi","doi":"10.38192/1.6.3.10","DOIUrl":"https://doi.org/10.38192/1.6.3.10","url":null,"abstract":"Introduction: Ophthalmology services have been significantly impacted by the COVID-19 pandemic. Frequency of intravitreal anti-vascular endothelial growth factor (Anti-VEGF) injections are important in visual outcomes.\u0000Methods: We conducted an audit on intravitreal services in an NHS district general hospital in the UK including all new patients with diabetic macular oedema (CI-DMO) and wet age-related macular degeneration (AMD) who were initiated on intravitreal injection of Aflibercept (EYLEA) between 1st January to 15th July 2020, and had subsequent injections until October 2020. Data on injection dates and visual acuity was extracted, and the total number of all intravitreal injections for all indications between January to September 2020 and the same period in 2019. Delay to treatment was defined as more than 14 days, according to the fixed dosing schedule.\u0000Results: We found 31% (n=17) of patients initiated on treatment for wet AMD and 44% (N=11) for CI-DMO had delayed injections.  There was no correlation between total duration of delay and change in best-corrected visual acuity (BCVA). Similarly, we found no association between duration of delay and change in BCVA. The number of intravitreal injections declined during the COVID-19 pandemic by 17.8% compared to 2019.\u0000Conclusion: Majority of patients initiated on anti-VEGF injections just before the pandemic or during the pandemic received injections on time. Where there were significant delays to treatment, there was no detected loss in vision over the short term. However, the long-term impact and impact of overall reduction in intravitreal injections are unknown.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89338377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Assessing Vision in Elderly Patients Admitted to Hospital Following a Fall 老年人跌倒后入院的视力评估
Pub Date : 2020-12-20 DOI: 10.38192/1.6.3.8
M. Rahimzadeh, G. S. Alg, Aisling Robinson, A. Moseley
Introduction: Falls are a major cause of morbidity and mortality in older people, and those with reduced visual acuity are twice as likely to fall as those with normal eyesight. Accordingly, NICE guidelines recommend assessment of vision as part of a multi-factorial risk assessment in older people, who present for medical attention, because of a fall.Methods: We included all patients admitted to a senior health ward at St George’s hospital because of a fall. A baseline audit was conducted in May 2020. Our primary intervention was a departmental teaching session with subsequent first cycle data. We trialled the ‘Lookout! Bedside vision check for falls prevention’ recommended by the Royal College of Physicians. Our secondary intervention was designing an ‘initial assessment’ proforma to include a section for sensory impairment followed by a second cycle data collection.Results: Our initial results showed that none of the 24 patients admitted with a fall had any form of documented visual assessment. Using a simple bedside vision check tool, we found 22% (n=2) of screened patients had significantly impaired vision. Following our teaching session, 50% (n=7) of patients had some form of visual assessment on admission and after introduction of the proforma, this increased to 56% (n=5). Visual risk factors were identified in multiple patients, including outdated prescriptions for corrective glasses.Discussion: Identifying reversible visual risk factors may reduce recurrent falls and subsequent complications as well as hospital admissions in older patients. A teaching session was found to be effective, however a ‘proforma’ may encourage more sustainable improvements. The reduction in ophthalmology and optometry services during the Covid-19 pandemic will inevitably increase the prevalence of visual risk factors. Effects including delayed eyesight tests and cataract operations. It is therefore more important now than ever, to ensure bedside assessment of vision in older adults presenting to hospital, with a fall and proactively in falls prevention strategies.
引言:跌倒是老年人发病和死亡的主要原因,视力下降的人跌倒的可能性是视力正常的人的两倍。因此,NICE指南建议对因跌倒就诊的老年人进行视力评估,作为多因素风险评估的一部分。方法:我们纳入了所有因跌倒而入住圣乔治医院高级健康病房的患者。2020年5月进行了一次基线审计。我们的主要干预措施是一个部门的教学会议,随后的第一个周期的数据。我们试了“瞭望!”英国皇家内科医师学院建议进行床边视力检查,以预防跌倒。我们的次要干预措施是设计一个“初步评估”形式,其中包括一个部分的感觉障碍,然后是第二个周期的数据收集。结果:我们的初步结果显示,24例因跌倒入院的患者中没有任何形式的书面视力评估。使用简单的床边视力检查工具,我们发现22% (n=2)的筛查患者视力明显受损。在我们的教学课程之后,50% (n=7)的患者在入院时进行了某种形式的视觉评估,在引入形式评估后,这一比例增加到56% (n=5)。在多名患者中发现了视力风险因素,包括过时的矫正眼镜处方。讨论:识别可逆性视力危险因素可以减少老年患者的复发性跌倒和随后的并发症以及住院率。教学环节被发现是有效的,然而“形式”可能会鼓励更可持续的改进。在2019冠状病毒病大流行期间,眼科和验光服务的减少将不可避免地增加视力危险因素的流行。影响包括延迟视力检查和白内障手术。因此,现在比以往任何时候都更重要的是,确保对住院的老年人进行床边视力评估,并积极采取预防跌倒的策略。
{"title":"Assessing Vision in Elderly Patients Admitted to Hospital Following a Fall","authors":"M. Rahimzadeh, G. S. Alg, Aisling Robinson, A. Moseley","doi":"10.38192/1.6.3.8","DOIUrl":"https://doi.org/10.38192/1.6.3.8","url":null,"abstract":"Introduction: Falls are a major cause of morbidity and mortality in older people, and those with reduced visual acuity are twice as likely to fall as those with normal eyesight. Accordingly, NICE guidelines recommend assessment of vision as part of a multi-factorial risk assessment in older people, who present for medical attention, because of a fall.\u0000Methods: We included all patients admitted to a senior health ward at St George’s hospital because of a fall. A baseline audit was conducted in May 2020. Our primary intervention was a departmental teaching session with subsequent first cycle data. We trialled the ‘Lookout! Bedside vision check for falls prevention’ recommended by the Royal College of Physicians. Our secondary intervention was designing an ‘initial assessment’ proforma to include a section for sensory impairment followed by a second cycle data collection.\u0000Results: Our initial results showed that none of the 24 patients admitted with a fall had any form of documented visual assessment. Using a simple bedside vision check tool, we found 22% (n=2) of screened patients had significantly impaired vision. Following our teaching session, 50% (n=7) of patients had some form of visual assessment on admission and after introduction of the proforma, this increased to 56% (n=5). Visual risk factors were identified in multiple patients, including outdated prescriptions for corrective glasses.\u0000Discussion: Identifying reversible visual risk factors may reduce recurrent falls and subsequent complications as well as hospital admissions in older patients. A teaching session was found to be effective, however a ‘proforma’ may encourage more sustainable improvements. The reduction in ophthalmology and optometry services during the Covid-19 pandemic will inevitably increase the prevalence of visual risk factors. Effects including delayed eyesight tests and cataract operations. It is therefore more important now than ever, to ensure bedside assessment of vision in older adults presenting to hospital, with a fall and proactively in falls prevention strategies.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76496027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
After the Pandemic 大流行之后
Pub Date : 2020-09-13 DOI: 10.38192/1.6.2.25
I. Chakravorty, A. Chopada, V. Zamvar
Editorial explores the health and economic impact of the COVID-19 pandemic as the world reeling from the initial surge prepares for the second. 
这篇社论探讨了COVID-19大流行对健康和经济的影响,目前世界正从最初的疫情激增中恢复过来,为第二次疫情做准备。
{"title":"After the Pandemic","authors":"I. Chakravorty, A. Chopada, V. Zamvar","doi":"10.38192/1.6.2.25","DOIUrl":"https://doi.org/10.38192/1.6.2.25","url":null,"abstract":"Editorial explores the health and economic impact of the COVID-19 pandemic as the world reeling from the initial surge prepares for the second. ","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81211321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcium imbalance in Sarcoidosis and Renal Failure 结节病与肾衰竭的钙失衡
Pub Date : 2020-08-23 DOI: 10.38192/1.6.2.21
A. Sathyanarayan
Poster presented at BAPIO National Conference, London Nov 2019 Peer reviewed by Subarna Chakravorty & Sunil Daga
2019年11月在伦敦举行的BAPIO全国会议上发表的海报,由Subarna Chakravorty和Sunil Daga进行同行评审
{"title":"Calcium imbalance in Sarcoidosis and Renal Failure","authors":"A. Sathyanarayan","doi":"10.38192/1.6.2.21","DOIUrl":"https://doi.org/10.38192/1.6.2.21","url":null,"abstract":"Poster presented at BAPIO National Conference, London Nov 2019 \u0000Peer reviewed by Subarna Chakravorty & Sunil Daga","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78994601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relevance of FGFR1-NMDAR2B heteroreceptor complexes in treating major depressive disorder FGFR1-NMDAR2B异受体复合物在治疗重度抑郁症中的相关性
Pub Date : 2020-08-03 DOI: 10.38192/1.6.2.13
Ashwin Venkatesh
Poster presented at BAPIO National Conference, London 2019 Peer reviewed by Subarna Chakravorty PhD & Sunil Daga PhD
在2019年伦敦BAPIO全国会议上发表的海报,由Subarna Chakravorty博士和Sunil Daga博士同行评审
{"title":"Relevance of FGFR1-NMDAR2B heteroreceptor complexes in treating major depressive disorder","authors":"Ashwin Venkatesh","doi":"10.38192/1.6.2.13","DOIUrl":"https://doi.org/10.38192/1.6.2.13","url":null,"abstract":"Poster presented at BAPIO National Conference, London 2019 \u0000Peer reviewed by Subarna Chakravorty PhD & Sunil Daga PhD","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73383219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an acute general paediatrics service specification at a major London teaching hospital 伦敦一家大型教学医院急性普通儿科服务规范的制定
Pub Date : 2020-07-30 DOI: 10.38192/1.6.2.8
J. Avery
Poster presented at BAPIO National Conference, London 2019 Peer reviewed by Subarna Chakravorty PhD & Sunil Daga PhD The new service specification will be used by clinical staff to reflect on practice and outcomes. It enables clinicians to identify standards, rather than accessing them from various sources. It will aid the planning, commissioning, and provision of acute paediatric services and provide a framework against which to audit provision and demonstrate improvement. It would be possible to translate this for use across the UK.
由Subarna Chakravorty博士和Sunil Daga博士进行同行评审。新的服务规范将被临床工作人员用来反思实践和结果。它使临床医生能够确定标准,而不是从各种来源获取标准。它将有助于规划、启用和提供急性儿科服务,并提供一个框架,据此审计提供的服务和证明改进情况。这将有可能被翻译成在整个英国使用。
{"title":"Development of an acute general paediatrics service specification at a major London teaching hospital","authors":"J. Avery","doi":"10.38192/1.6.2.8","DOIUrl":"https://doi.org/10.38192/1.6.2.8","url":null,"abstract":"Poster presented at BAPIO National Conference, London 2019 \u0000Peer reviewed by Subarna Chakravorty PhD & Sunil Daga PhD \u0000The new service specification will be used by clinical staff to reflect on practice and outcomes. It enables clinicians to identify standards, rather than accessing them from various sources. It will aid the planning, commissioning, and provision of acute paediatric services and provide a framework against which to audit provision and demonstrate improvement. It would be possible to translate this for use across the UK.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87441566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Pandemic COVID-19大流行
Pub Date : 2020-03-14 DOI: 10.38192/1.6.1.1
Ananthakrishnan Raghuraman
In December 2019, a cluster of cases of pneumonia of unknown cause was detected in Wuhan, Hubei Province, China. A novel coronavirus (SARS coronavirus-2 (SARS-CoV-2)) was subsequently identified. The associated disease is now referred to as COVID-19. The source of the outbreak has yet to be determined. A zoonotic source to the outbreak has not been identified yet, but investigations are ongoing.
2019年12月,中国湖北省武汉市发现了一宗不明原因肺炎聚集性病例。随后发现了一种新型冠状病毒(SARS冠状病毒-2 (SARS- cov -2))。相关疾病现在被称为COVID-19。爆发的源头尚未确定。暴发的人畜共患源尚未确定,但正在进行调查。
{"title":"COVID-19 Pandemic","authors":"Ananthakrishnan Raghuraman","doi":"10.38192/1.6.1.1","DOIUrl":"https://doi.org/10.38192/1.6.1.1","url":null,"abstract":"In December 2019, a cluster of cases of pneumonia of unknown cause was detected in Wuhan, Hubei Province, China. A novel coronavirus (SARS coronavirus-2 (SARS-CoV-2)) was subsequently identified. The associated disease is now referred to as COVID-19. The source of the outbreak has yet to be determined. A zoonotic source to the outbreak has not been identified yet, but investigations are ongoing.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"56 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91384892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Cough 慢性咳嗽
Pub Date : 2020-01-19 DOI: 10.38192/1.6.1.5
Triya Chakravorty, I. Chakravorty
Cough is a common manifestation of many respiratory conditions and mostly is non-specific on its own as a symptom of the underlying disease. Most transient coughing episodes tend to settle within 2-3 weeks. Yet cough can herald more sinister disease such as malignancy or progressive respiratory conditions. In epidemiological surveys, cough persisting more than 8 weeks has been shown to have a significant impact on the quality of life and is often difficult to diagnose and treat, taking weeks to months. There is consensus that a logical, evidence-based, standardised approach is most likely to lead to an efficient diagnosis and provide the highest chance of effective resolution. This paper describes the current evidence and offers a best practice approach for primary care practitioners and general internists.
咳嗽是许多呼吸系统疾病的一种常见表现,大多数情况下,咳嗽本身并不是潜在疾病的一种症状。大多数短暂的咳嗽发作往往在2-3周内消退。然而,咳嗽可能预示着更险恶的疾病,如恶性肿瘤或进行性呼吸系统疾病。流行病学调查显示,持续8周以上的咳嗽会对生活质量产生重大影响,而且往往难以诊断和治疗,需要数周至数月时间。人们一致认为,合乎逻辑的、以证据为基础的标准化方法最有可能导致有效的诊断,并提供最高的有效解决机会。本文描述了目前的证据,并为初级保健医生和普通内科医生提供了最佳实践方法。
{"title":"Chronic Cough","authors":"Triya Chakravorty, I. Chakravorty","doi":"10.38192/1.6.1.5","DOIUrl":"https://doi.org/10.38192/1.6.1.5","url":null,"abstract":"Cough is a common manifestation of many respiratory conditions and mostly is non-specific on its own as a symptom of the underlying disease. Most transient coughing episodes tend to settle within 2-3 weeks. Yet cough can herald more sinister disease such as malignancy or progressive respiratory conditions. In epidemiological surveys, cough persisting more than 8 weeks has been shown to have a significant impact on the quality of life and is often difficult to diagnose and treat, taking weeks to months. There is consensus that a logical, evidence-based, standardised approach is most likely to lead to an efficient diagnosis and provide the highest chance of effective resolution. This paper describes the current evidence and offers a best practice approach for primary care practitioners and general internists.","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83471016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are Circulating miRNAs Predictive of Response to Therapy? 循环mirna能预测治疗反应吗?
Pub Date : 2019-06-24 DOI: 10.38192/1.6.1.C11
L. Kannappa
Colorectal cancer (CRC) is the third commonest cancer with nearly 1.4 million new cases identified throughout the world in 2012. There is a pressing need for a new non-invasive blood-based test to improve early detection and monitoring of CRC. MiRNAs are small non-coding RNAs involved in fundamental cell processes such as proliferation, survival and death. Studies have identified miRNAs in plasma of cancer patients in a stable form. This study aimed to evaluate whether circulating microRNAs are predictive of response to therapy. 
结直肠癌(CRC)是第三大常见癌症,2012年全球有近140万新发病例。迫切需要一种新的无创血液检测来改善CRC的早期发现和监测。mirna是一种小的非编码rna,参与细胞增殖、存活和死亡等基本过程。研究已经在癌症患者的血浆中发现了稳定形式的mirna。本研究旨在评估循环microrna是否能预测治疗反应。
{"title":"Are Circulating miRNAs Predictive of Response to Therapy?","authors":"L. Kannappa","doi":"10.38192/1.6.1.C11","DOIUrl":"https://doi.org/10.38192/1.6.1.C11","url":null,"abstract":"Colorectal cancer (CRC) is the third commonest cancer with nearly 1.4 million new cases identified throughout the world in 2012. There is a pressing need for a new non-invasive blood-based test to improve early detection and monitoring of CRC. MiRNAs are small non-coding RNAs involved in fundamental cell processes such as proliferation, survival and death. Studies have identified miRNAs in plasma of cancer patients in a stable form. This study aimed to evaluate whether circulating microRNAs are predictive of response to therapy. ","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75610605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preface to the First Edition 第一版序言
Pub Date : 2018-09-20 DOI: 10.2307/j.ctvdmwxv4.6
C. Hering
{"title":"Preface to the First Edition","authors":"C. Hering","doi":"10.2307/j.ctvdmwxv4.6","DOIUrl":"https://doi.org/10.2307/j.ctvdmwxv4.6","url":null,"abstract":"","PeriodicalId":75015,"journal":{"name":"The Homoeopathic physician","volume":"37 1","pages":"S5 - S9"},"PeriodicalIF":0.0,"publicationDate":"2018-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87690593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Homoeopathic physician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1